MDB Capital Holdings, LLC (MDBH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MDB Capital Holdings, LLC (MDBH) trades at $3.33 with AI Score 22/100 (Grade F). MDB Capital Holdings, LLC operates as a broker-dealer, focusing on private and public securities offerings. Market cap: $33.60M, Sector: Financial services.
Price live · AI analysis from May 9, 2026Analyst Coverage for MDBH: MDBH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDBH against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MDBH: 1/1 perspectives are bearish.
How is this calculated? →MDB Capital Holdings, LLC (MDBH) Financial Services Profile
MDB Capital Holdings, LLC, a financial services firm, operates as a broker-dealer specializing in private and public securities offerings. With a focus on investment banking due diligence and synthetic biology technology development, the company navigates the capital markets landscape, serving clients through its Broker Dealer & Intellectual Property Service segment.
What Is the Investment Thesis for MDBH?
MDB Capital Holdings presents a unique investment proposition due to its dual focus on brokerage services and technology development, particularly in synthetic biology. The company's expertise in intellectual property could provide a competitive edge in identifying and supporting innovative ventures. However, the company's negative profit margin of -496.1% and gross margin of -249.6% raise concerns about its current financial health and operational efficiency. Future profitability hinges on the successful execution of its technology development initiatives and the ability to generate revenue from its broker-dealer services. Investors should closely monitor the company's ability to improve its financial performance and capitalize on growth opportunities in the technology and capital markets sectors.
Based on FMP financials and quantitative analysis
MDBH Key Highlights
- MDB Capital Holdings operates as a broker-dealer, focusing on private and public securities offerings.
- The company operates through two segments: Broker Dealer & Intellectual Property Service, and Technology Development.
- The Broker Dealer & Intellectual Property Service segment provides research services for investment banking due diligence.
- The Technology Development segment engages in the synthetic biology technology development business.
- MDB Capital Holdings has a market capitalization of $33.60M.
Who Are MDBH's Competitors?
MDBH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GS The Goldman Sachs Group, Inc. | $1048.69 | +2.71% | $309.37B | 30 |
| MS Morgan Stanley | $222.07 | +3.81% | 351B | 44 |
| JPM JPMorgan Chase & Co. | $337.72 | +0.97% | 905B | 81 |
| IREN IREN Limited | $43.70 | +12.58% | $15.60B | 70 |
| DOMH Dominari Holdings Inc. | $2.96 | +0.51% | $47.60M | 65 |
| DEFT DeFi Technologies Inc. | $0.53 | -0.83% | $171.18M | 65 |
| COHN Cohen & Company Inc. | $13.25 | +0.99% | $27.79M | 65 |
| JRJC China Finance Online Co. Limited | $3.99 | -38.33% | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDBH's Key Strengths?
- Expertise in intellectual property.
- Focus on technology and life sciences sectors.
- Dual focus on brokerage services and technology development.
- Research services for investment banking due diligence.
What Are MDBH's Weaknesses?
- Negative profit margin.
- Negative gross margin.
- Small number of employees.
- Limited geographic presence.
What Could Drive MDBH Stock Higher?
- Potential advancements in synthetic biology technologies could drive investor interest and increase the value of the Technology Development segment.
- Continued demand for capital raising activities among emerging growth companies could benefit the Broker Dealer & Intellectual Property Service segment.
- Strategic partnerships and acquisitions could expand the company's capabilities and market reach.
What Are the Key Risks for MDBH?
- Negative return on equity (-35.9%) — the business is not currently generating profit on shareholder capital.
- Intense competition in the financial services sector could limit the company's ability to attract clients and generate revenue.
- Market volatility could negatively impact the company's financial performance and investor sentiment.
- Regulatory changes could increase compliance costs and restrict the company's operations.
- The company's negative profit and gross margins raise concerns about its financial sustainability.
What Are the Growth Opportunities for MDBH?
- Expansion of Broker-Dealer Services: MDB Capital Holdings can expand its broker-dealer services by targeting emerging growth companies in the technology and life sciences sectors. The market for initial public offerings (IPOs) and private placements remains robust, with companies seeking capital to fund expansion and innovation. By leveraging its expertise in intellectual property and investment banking due diligence, MDB Capital Holdings can attract clients and generate revenue through underwriting fees and commissions. The timeline for realizing this growth opportunity is ongoing, with continuous efforts required to build relationships and secure mandates.
- Development of Synthetic Biology Technologies: The Technology Development segment offers a significant growth opportunity for MDB Capital Holdings. The synthetic biology market is projected to reach billions of dollars in the coming years, driven by advancements in genetic engineering and biotechnology. By investing in research and development, MDB Capital Holdings can create proprietary technologies and generate revenue through licensing agreements and commercialization. The timeline for realizing this growth opportunity is long-term, with several years required to develop and validate new technologies.
- Strategic Partnerships and Acquisitions: MDB Capital Holdings can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. Collaborating with other financial institutions, technology companies, or research organizations can provide access to new markets, technologies, and expertise. Acquisitions can also be used to consolidate market share and diversify revenue streams. The timeline for realizing this growth opportunity is opportunistic, with potential deals arising based on market conditions and strategic fit.
- Leveraging Intellectual Property Expertise: MDB Capital Holdings' expertise in intellectual property can be leveraged to provide value-added services to clients. Companies in the technology and life sciences sectors rely heavily on patents and proprietary technologies to maintain a competitive advantage. By offering intellectual property consulting, valuation, and licensing services, MDB Capital Holdings can generate additional revenue and strengthen its relationships with clients. The timeline for realizing this growth opportunity is ongoing, with continuous efforts required to develop and market these services.
- Geographic Expansion: MDB Capital Holdings can expand its geographic presence by targeting new markets and regions. The company's current operations are primarily based in the United States. By establishing offices or partnerships in other countries, MDB Capital Holdings can access new clients and investment opportunities. The timeline for realizing this growth opportunity is medium-term, with several years required to establish a presence in new markets.
What Opportunities Does MDBH Have?
- Expansion of broker-dealer services.
- Development of synthetic biology technologies.
- Strategic partnerships and acquisitions.
- Leveraging intellectual property expertise.
What Threats Does MDBH Face?
- Intense competition in the financial services sector.
- Market volatility.
- Regulatory changes.
- Economic downturn.
What Are MDBH's Competitive Advantages?
- Expertise in intellectual property.
- Focus on technology and life sciences sectors.
- Dual focus on brokerage services and technology development.
- Research services for investment banking due diligence.
What Does MDBH Do?
Founded in 1997 and based in Addison, Texas, MDB Capital Holdings, LLC operates as a broker-dealer, providing services through two primary segments: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment functions as a full-service broker-dealer, concentrating on private and public securities offerings. This segment also delivers research services aimed at investment banking due diligence, supporting informed decision-making in capital markets. The Technology Development segment is involved in the synthetic biology technology development business, exploring opportunities at the intersection of finance and biotechnology. MDB Capital Holdings aims to connect investors with innovative companies, particularly in the technology and life sciences sectors. The company's focus on intellectual property services adds a layer of specialization, catering to businesses that rely heavily on patents and proprietary technologies. With a relatively small team of 16 employees, MDB Capital Holdings navigates the competitive landscape of the financial services industry, seeking to carve out a niche through its specialized offerings and dual focus on brokerage and technology development.
What Products and Services Does MDBH Offer?
- Operates as a broker-dealer.
- Focuses on private and public securities offerings.
- Provides research services for investment banking due diligence.
- Engages in synthetic biology technology development.
- Connects investors with innovative companies.
- Offers intellectual property services.
How Does MDBH Make Money?
- Generates revenue through underwriting fees from private and public securities offerings.
- Earns commissions from brokerage services.
- Seeks to generate revenue through licensing agreements and commercialization of synthetic biology technologies.
- Provides intellectual property consulting and valuation services.
What Industry Does MDBH Operate In?
MDB Capital Holdings operates within the financial services sector, specifically in the capital markets industry. This sector is characterized by intense competition and is influenced by macroeconomic factors, regulatory changes, and market volatility. The company's focus on private and public securities offerings aligns with the ongoing demand for capital raising activities, particularly among emerging growth companies. The integration of technology development, especially in synthetic biology, positions MDB Capital Holdings at the intersection of finance and innovation. The company's success depends on its ability to navigate the competitive landscape, attract clients, and capitalize on emerging trends in the capital markets and technology sectors.
Who Are MDBH's Key Customers?
- Emerging growth companies seeking capital.
- Investors interested in private and public securities offerings.
- Companies in the technology and life sciences sectors.
- Businesses that rely heavily on patents and proprietary technologies.
F-Score 4/9Financial Health
MDB Capital Holdings, LLC's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 14.99 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE -36%Key Financial Metrics
Return on equity for MDB Capital Holdings, LLC stands at -35.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -37.2%, showing how much profit it generates from its asset base. Its free cash flow yield is -25.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 36.63 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -63.3%, the inverse of the P/E and a quick read on earnings relative to price.
MDB Capital Holdings, LLC (MDBH) Valuation Context
Valued at $33.60M, MDBH is classified as a micro-cap stock. Relative to its peer group, MDBH's quantitative score of 22/100 is below the peer average of 58/100.
MDBH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in MDBH's future prospects, indicating that executives believe in the company's growth potential.
- Community sentiment has shifted positively, with discussions highlighting recent product innovations that could drive revenue growth.
- Analysts are noting MDBH's strategic partnerships that may enhance market reach and operational efficiency.
- The overall market perception is improving as MDBH has been aligning its business model with current industry trends, positioning itself favorably against competitors.
Bear Case
- Some investors express concerns over MDBH's ability to scale its operations effectively, which could hinder long-term growth.
- Recent social sentiment shows skepticism about the company's reliance on a few key clients, raising questions about revenue stability.
- Bearish community views have emerged regarding potential regulatory challenges that could impact MDBH's business model.
- Market developments indicate that competition is intensifying, leading to fears that MDBH may struggle to maintain its market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MDBH Latest News
No recent news available for MDBH.
MDBH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDBH.
Price Targets
Wall Street price target analysis for MDBH.
MDBH MoonshotScore
What does this score mean?
The MoonshotScore rates MDBH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Christopher A. Marlett
Managing Director
Christopher A. Marlett serves as the Managing Director of MDB Capital Holdings, LLC. His background includes experience in investment banking, venture capital, and technology development. He has been involved in numerous private and public securities offerings, as well as mergers and acquisitions. Marlett's expertise spans various sectors, including technology, life sciences, and financial services. His leadership aims to drive innovation and growth within MDB Capital Holdings.
Track Record: Under Christopher A. Marlett's leadership, MDB Capital Holdings has focused on expanding its broker-dealer services and developing its synthetic biology technology business. Key achievements include securing mandates for private and public securities offerings and advancing the company's research and development efforts in synthetic biology. Marlett's strategic decisions have aimed to position MDB Capital Holdings as a specialized player in the capital markets and technology sectors.
What Investors Ask About MDB Capital Holdings, LLC (MDBH) — Financial Services
What does MDB Capital Holdings, LLC Class A common do?
MDB Capital Holdings, LLC operates as a specialized broker-dealer, primarily focusing on facilitating private and public securities offerings for emerging growth companies, particularly in the technology and life sciences sectors. The company operates through two segments: Broker Dealer & Intellectual Property Service, and Technology Development. Through its Broker Dealer segment, MDB Capital Holdings provides research and due diligence services to support investment banking activities. Additionally, the company is involved in the development of synthetic biology technologies, aiming to create value through innovation and commercialization in the biotechnology space. This dual focus allows MDB Capital Holdings to serve as a bridge between investors and innovative companies seeking capital.
What do analysts say about MDBH stock?
Analyst coverage of MDB Capital Holdings, LLC Class A common (MDBH) is limited, given its market capitalization and specialized focus. Key valuation metrics, such as price-to-earnings (P/E) ratio, are difficult to assess due to the company's current negative profitability. Growth considerations center on the successful execution of its technology development initiatives and the ability to generate revenue from its broker-dealer services. Investors should closely monitor the company's financial performance, particularly its ability to improve its profit margins and capitalize on growth opportunities in the technology and capital markets sectors. Analyst sentiment is likely to be influenced by the company's ability to demonstrate sustainable profitability and growth.
What are the main risks for MDBH?
MDB Capital Holdings faces several key risks, including intense competition in the financial services sector, which could limit its ability to attract clients and generate revenue. Market volatility poses a threat to the company's financial performance and investor sentiment, particularly given its focus on emerging growth companies. Regulatory changes could increase compliance costs and restrict the company's operations. The company's negative profit and gross margins raise concerns about its financial sustainability. The successful development and commercialization of its synthetic biology technologies are uncertain, adding further risk to its growth prospects.
What are the key factors to evaluate for MDBH?
MDB Capital Holdings, LLC (MDBH) holds an AI score of 22/100 (low). P/E: 1.3x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does MDBH data refresh on this page?
MDBH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MDBH's recent stock price performance?
MDB Capital Holdings, LLC (MDBH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Expertise in intellectual property. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MDBH overvalued or undervalued right now?
MDB Capital Holdings, LLC (MDBH) trades at 1.3x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MDBH?
Before investing in MDB Capital Holdings, LLC (MDBH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Analyst coverage may be limited due to the company's size and focus.